Angela Teng

Suggest Changes
  • Citations Per Year
Learn More
6600 Background: Decitabine is a therapy for myelodysplastic syndromes (MDS). Myelosuppression is typical of MDS and a common toxicity of decitabine, and may result in dose modification (reduction(More)
BACKGROUND After the World Health Organization (WHO) changed the definition of acute myeloid leukemia (AML) to ≥ 20% blasts, the International Working Group (IWG) response criteria for myelodysplasia(More)
  • 1